Replies to post #241100 on Biotech Values

[DewDiligence]

ENTA new corporate slide set:

https://s22.q4cdn.com/306858242/files/doc_presentations/2022/01/Enanta-Corporate-Presentation-1.6.22-Final.pdf

[DewDiligence]

ENTA’s phase-2b trial in RSV misses primary endpoint:

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-reports-topline-data-rsvp-study-edp-938

From the recent price action, it seems that this result may have been leaked.